TLPHTalphera, Inc.

$18M

Q4 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$1M

Operating Income

-$3M

Net Income

-$2M

EPS (Diluted)

$-0.07

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$230,000

Balance Sheet

Total Assets

$18M

Total Liabilities

$10M

Stockholders' Equity

$8M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$281,000	-100.0%
Gross Profit	-$1M	-$1M	+11.1%
Operating Income	-$3M	-$4M	+30.0%
Net Income	-$2M	-$5M	+58.6%

TLPH Q4 2024 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena